Back to Top Skip to main content

Voluntary drug recall alert: Valsartan

Take Command of your health Take Command of your health

Recommended Content:

TRICARE Health Program

On July 13, 2018, the Food and Drug Administration (FDA) issued a voluntary recall of valsartan. Valsartan is used to treat high blood pressure and heart failure.

The FDA announced the voluntary recall after finding an impurity linked to cancer in drug products containing valsartan.

Not all valsartan-containing drugs are affected and have been recalled.

Express Scripts identified 31,120 TRICARE beneficiaries who potentially received contaminated products through the mail order network or from retail pharmacies. The Department of Defense (DoD) sent notification letters to all beneficiaries who potentially received currently affected products.

The FDA notes that because this is an ongoing investigation, more manufacturers may voluntarily recall their valsartan products. If additional valsartan products are added to the recall list, the DoD will continue to send letters to TRICARE beneficiaries who received contaminated products.

Patients and prescribers are also encouraged to check the FDA website often for potential changes in the recall status of their valsartan medicine.

If you take valsartan, the FDA recommends:

  • Continue taking your current medicine until your doctor or pharmacist gives you a replacement or a different treatment option.
  • If you are taking any medication containing valsartan, compare the information on your prescription bottle with the information in the recall list (company, National Drug Code, lot number) to determine if your current medicine has been recalled. If you are not certain, contact your pharmacist.
  • If you have medicine included in the recall, contact your pharmacist. The pharmacist may be able to provide you with valsartan made by another company. If not, contact your doctor immediately to discuss other treatment options.

You can find the latest information about the recall and affected products on the FDA website.

If you have more questions about the recall, contact the FDA or the Defense Health Agency (DHA) Pharmacy Operations:

You also may be interested in...

TRICARE Prime and TRICARE Select Out-of-Pocket Expenses for Calendar Year 2020

Policy

Memo outlining the TRICARE Prime and TRICARE Select beneficiary out-of-pocket expenses for calendar year 2020. These rates will be effective January l, 2020.

MHS Minute January 2020

Video
1/21/2020
MHS Minute January 2020

Thanks for tuning in to the *NEW* MHS Minute! Check back each month to learn about more exciting events and achievements by organizations and partners across the Military Health System!

Recommended Content:

MHS Transformation | TRICARE Health Program

Changes in TRICARE Plan Enrollment (July 2019)

Report
1/9/2020

To assess the impact of plan changing in TRICARE, we examined data from the first quarter of the 2019 Health Care Survey of Department of Defense Beneficiaries (HCSDB), which was fielded during open enrollment.

Recommended Content:

Health Care Survey of DoD Beneficiaries | TRICARE Health Program

Achievements in 2019 provide strong foundation for year ahead

Article
12/23/2019
A Year in Review: Year of Military Health 2019

Dedication, commitment to mission praised as changes continue

Recommended Content:

TRICARE Health Program | MHS GENESIS | Research and Innovation | Preventive Health | MHS Transformation

New 3-D mammogram option the next step in diagnosis, treatment

Article
12/19/2019
Chief Hospital Corpsman Naomi Perez, a certified mammogram technician (left), conducts a mammogram for a patient at Naval Hospital Pensacola. A mammogram is a low-dose X-ray procedure used to detect the early stages of breast cancer. A policy change effective Jan. 1, 2020, will allow digital breast tomosynthesis, or 3-D mammography, to be used to screen for breast cancer. The procedure – known technically as Digital Breast Tomosynthesis (DBT) – will be offered primarily to women age 40 and older, and women age 30 and older who are considered high-risk for breast cancer.  The procedure’s 3-D images provide a more thorough means of detecting the disease. (U.S. Navy Photo by Mass Communication Specialist 1st Class Brannon Deugan)

Procedure would enhance effectiveness of breast cancer screening

Recommended Content:

TRICARE Health Program | Women's Health

3D Mammography Toolkit

Publication
12/19/2019

Recommended Content:

3-D Mammography | TRICARE Health Program | Women's Health

3D Mammogram Screensaver

Photo
12/17/2019
This graphic states information about 3-D Mammography

Share this screensaver to spread the word about 3-D Mammography coverage

Recommended Content:

3-D Mammography | Access to Health Care | TRICARE Health Program

3D Mammogram Facebook Post

Photo
12/17/2019
This graphic states information about 3-D Mammography

Share this graphic to spread the word about 3-D Mammography coverage

Recommended Content:

3-D Mammography | TRICARE Health Program

3D Mammography Infographic 1

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health | 3-D Mammography

3D Mammography Infographic 2

Publication
12/16/2019

Share this infographic to spread the word about 3-D Mammography coverage

Recommended Content:

TRICARE Health Program | Women's Health | 3-D Mammography

Talking_Points_3D_Mammography

Publication
12/16/2019

These talking points share information about 3-D mammography

Recommended Content:

TRICARE Health Program | Women's Health | 3-D Mammography

TRICARE Specialty Drug Network Accessibility

Congressional Testimony
12/13/2019

H.R. 2500, HASC Report for FY 2020, 116-120, Pg. 167

Recommended Content:

TRICARE Health Program

Open Season and BWE Issue Annex

Publication
11/23/2019

This Open Season and BWE Issue Annex contains products with additional information about how to enroll during Open Season

Recommended Content:

Open Season 2019 | TRICARE Health Program

Open Season Logo ANNEX Secondary Logo

Photo
11/22/2019
This logo is a reminder that Open Season is Nov 11 to Dec 9, 2019

Share this on social media!

Recommended Content:

TRICARE Health Program | Open Season 2019

Open Season Logo ANNEX Primary Logo

Photo
11/22/2019
This logo is a reminder that Open Season is Nov 11 to Dec 9, 2019

Share this on social media!

Recommended Content:

TRICARE Health Program | Open Season 2019
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 17

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.